{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:37:55Z","timestamp":1792859875541,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005001","name":"Ahvaz Jundishapur University of Medical Sciences","doi-asserted-by":"publisher","award":["HLRC-9607"],"award-info":[{"award-number":["HLRC-9607"]}],"id":[{"id":"10.13039\/501100005001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Vitamin D deficiency is prevalent in patients with non-alcoholic fatty liver disease (NAFLD), but there are debates on the usefulness of vitamin D treatment. The interindividual variations in response may be due to different genetic backgrounds.<\/jats:p>\n                <jats:p>The present study evaluated the efficacy of calcitriol treatment in NAFLD patients with regard to the vitamin D receptor (VDR) genotypes of FokI polymorphism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study was conducted on 128 NAFLD patients randomly divided into two groups and were subjected to intervention with 0.25 mcg calcitriol\/day or placebo for 4\u2009months, while anthropometric parameters, glycemic status, lipid profiles, inflammatory markers, liver enzymes, and fatty liver indices were measured. The ARMS-PCR method was used to genotype the VDR FokI polymorphism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Calcitriol treatments along with weight loss and diet recommendations decreased the liver enzymes (AST, ALT, and ALP, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 for all) and fatty liver indices (HSI, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01 and APRI, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), compared to the baseline. But when the calcitriol effects were compared to the placebo group, only ALP decrease remained significant (17.5\u2009IU. <jats:italic>P<\/jats:italic>\u2009=\u20090.02). The prevalent FokI variants in our population were FF (53.1%) and Ff genotype (45.3%). No significant interaction of FokI variants to the calcitriol effects was found except for ALP. The decrease in the ALP activity was higher in calcitriol-received patients with the Ff genotype (<jats:italic>p<\/jats:italic>\u2009=\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The FF and Ff variants of VDR FokI polymorphism did not interact with the effects of calcitriol on fatty liver, but the ALP was more responsive in subjects with the Ff variant.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>IRCT registration number<\/jats:title>\n                <jats:p>IRCT2017053034222N1 Registration date: 2017-06-28 - Retrospectively registered, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/en.irct.ir\/trial\/26203\">https:\/\/en.irct.ir\/trial\/26203<\/jats:ext-link><\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40360-021-00485-y","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T12:03:19Z","timestamp":1617796999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The efficacy of calcitriol treatment in non-alcoholic fatty liver patients with different genotypes of vitamin D receptor FokI polymorphism"],"prefix":"10.1186","volume":"22","author":[{"given":"Hamid","family":"Yaghooti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Ghanavati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Saeed","family":"Seyedian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahman","family":"Cheraghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4175-8099","authenticated-orcid":false,"given":"Narges","family":"Mohammadtaghvaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"issue":"5","key":"485_CR1","doi-asserted-by":"publisher","first-page":"A65","DOI":"10.1016\/S0016-5085(01)80321-8","volume":"120","author":"JM Clark","year":"2001","unstructured":"Clark JM, Brancati FL, Diehl AME. Nonalcoholic fatty liver disease: the most common cause of abnormal liver enzymes in the US population. Gastroenterology. 2001;120(5):A65.","journal-title":"Gastroenterology"},{"issue":"6","key":"485_CR2","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.jhep.2011.10.027","volume":"56","author":"G Baffy","year":"2012","unstructured":"Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol. 2012;56(6):1384\u201391.","journal-title":"J Hepatol"},{"key":"485_CR3","doi-asserted-by":"crossref","unstructured":"Hariri M, Zohdi S. Effect of vitamin D on non-alcoholic fatty liver disease: a systematic review of randomized controlled clinical trials. Int J Prev Med. 2019;10:14.","DOI":"10.4103\/ijpvm.IJPVM_499_17"},{"issue":"10","key":"485_CR4","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.2337\/db08-0593","volume":"57","author":"NG Forouhi","year":"2008","unstructured":"Forouhi NG. Luan Ja, Cooper a, et al. baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely prospective study 1990\u20132000. Diabetes. 2008;57(10):2619\u201325.","journal-title":"Diabetes"},{"issue":"10","key":"485_CR5","first-page":"17221","volume":"8","author":"X Wang","year":"2015","unstructured":"Wang X, Li W, Zhang Y, et al. Association between vitamin D and non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: results from a meta-analysis. Int J Clin Exp Med. 2015;8(10):17221.","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"485_CR6","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/hep.26390","volume":"58","author":"RM Kwok","year":"2013","unstructured":"Kwok RM, Torres DM, Harrison SA. Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association? Hepatol. 2013;58(3):1166\u201374.","journal-title":"Hepatol"},{"key":"485_CR7","doi-asserted-by":"crossref","unstructured":"Papapostoli I, Lammert F, Stokes CS. Effect of short-term vitamin D correction on hepatic steatosis as quantified by Controlled Attenuation Parameter (CAP). J Gastrointestin Liver Dis. 2016;25(2):175\u201381.","DOI":"10.15403\/jgld.2014.1121.252.cap"},{"issue":"7","key":"485_CR8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.numecd.2006.04.002","volume":"17","author":"G Targher","year":"2007","unstructured":"Targher G, Bertolini L, Scala L, et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2007;17(7):517\u201324.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"4","key":"485_CR9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1530\/EJE-13-0609","volume":"170","author":"V Nobili","year":"2014","unstructured":"Nobili V, Giorgio V, Liccardo D, et al. Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease. Eur J Endocrinol. 2014;170(4):547\u201353.","journal-title":"Eur J Endocrinol"},{"key":"485_CR10","doi-asserted-by":"crossref","unstructured":"Bid HK, Konwar R, Aggarwal C, et al. Vitamin D receptor (FokI, BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus: a North Indian study. Indian J Med Sci. 2009;63(5):187\u201394.","DOI":"10.4103\/0019-5359.53164"},{"issue":"3","key":"485_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1463-1326.2007.00710.x","volume":"10","author":"X Palomer","year":"2008","unstructured":"Palomer X, Gonz\u00e1lez-Clemente J, Blanco-Vaca F, et al. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab. 2008;10(3):185\u201397.","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"485_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/oxfordjournals.epirev.a018033","volume":"22","author":"JM Zmuda","year":"2000","unstructured":"Zmuda JM, Cauley JA, Ferrell RE. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev. 2000;22(2):203\u201317.","journal-title":"Epidemiol Rev"},{"issue":"3","key":"485_CR13","doi-asserted-by":"publisher","first-page":"550","DOI":"10.2337\/dc12-0919","volume":"36","author":"TR Neyestani","year":"2013","unstructured":"Neyestani TR, Djazayery A, Shab-Bidar S, et al. Vitamin D receptor Fok-I polymorphism modulates diabetic host response to vitamin D intake: need for a nutrigenetic approach. Diabetes Care. 2013;36(3):550\u20136.","journal-title":"Diabetes Care"},{"issue":"4","key":"485_CR14","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1262-3636(07)70200-8","volume":"31","author":"A Reis","year":"2005","unstructured":"Reis A, Hauache O, Velho G. Vitamin D endocrine system and the genetic susceptibility to diabetes, obesity and vascular disease. A review of evidence. Diabetes Metab. 2005;31(4):318\u201325.","journal-title":"Diabetes Metab"},{"issue":"7","key":"485_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"D Matthews","year":"1985","unstructured":"Matthews D, Hosker J, Rudenski A, et al. Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","journal-title":"Diabetologia"},{"key":"485_CR16","unstructured":"Teimouri N, Nayeri H. Evaluation of multiple-scoring system for non-alcoholic fatty liver patients based on CK18 levels, lipid profile and liver enzymes. Feyz J Kashan Uni Med Sci. 2017;21."},{"key":"485_CR17","volume-title":"Extraction of genomic DNA from whole blood. Protocol Online-Your Lab's Reference Book\u2013online database of research protocols in a variety of life science fields [Electronic resource]\u2013 1999\u20132006","author":"L Boodram","year":"2004","unstructured":"Boodram L. Extraction of genomic DNA from whole blood. Protocol Online-Your Lab's Reference Book\u2013online database of research protocols in a variety of life science fields [Electronic resource]\u2013 1999\u20132006. 2004 Mode of access: http:\/\/www.protocolonline.org\/prot\/Protocols\/Extraction-of-genomic-DNA-from-whole-blood-3171.html."},{"issue":"8","key":"485_CR18","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.humimm.2006.04.008","volume":"67","author":"Z Lombard","year":"2006","unstructured":"Lombard Z, Dalton D-L, Venter PA, et al. Association of HLA-DR,-DQ, and vitamin D receptor alleles and haplotypes with tuberculosis in the Venda of South Africa. Hum Immunol. 2006;67(8):643\u201354.","journal-title":"Hum Immunol"},{"issue":"9","key":"485_CR19","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.molimm.2006.11.002","volume":"44","author":"C S\u00f8borg","year":"2007","unstructured":"S\u00f8borg C, Andersen AB, Range N, et al. Influence of candidate susceptibility genes on tuberculosis in a high endemic region. Mol Immunol. 2007;44(9):2213\u201320.","journal-title":"Mol Immunol"},{"issue":"1","key":"485_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s40291-013-0060-5","volume":"18","author":"M Jafari","year":"2014","unstructured":"Jafari M, Pirouzi A, Anoosheh S, et al. Rapid and simultaneous detection of vitamin D receptor gene polymorphisms by a single ARMS-PCR assay. Mol Diagn Ther. 2014;18(1):97\u2013103.","journal-title":"Mol Diagn Ther"},{"issue":"9","key":"485_CR21","first-page":"631","volume":"19","author":"S Agah","year":"2016","unstructured":"Agah S. Regression of non-alcoholic fatty liver by vitamin D supplement: a double-blind randomized controlled clinical trial. Arch Iran Med. 2016;19(9):631.","journal-title":"Arch Iran Med"},{"issue":"2","key":"485_CR22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s12020-012-9639-6","volume":"42","author":"S-S Moon","year":"2012","unstructured":"Moon S-S, Lee Y-S, Kim SW. Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women. Endocrine. 2012;42(2):423\u20139.","journal-title":"Endocrine"},{"key":"485_CR23","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1475-2891-12-96","volume":"12","author":"NJ Schuch","year":"2013","unstructured":"Schuch NJ, Garcia VC, V\u00edvolo SR, Martini LA. Relationship between Vitamin D Receptor gene polymorphisms and the components of metabolic syndrome. Nutr J. 2013;12:96.","journal-title":"Nutr J"},{"issue":"9","key":"485_CR24","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3390\/nu10091153","volume":"10","author":"A Cicero","year":"2018","unstructured":"Cicero A, Colletti A, Bellentani S. Nutraceutical approach to non-alcoholic fatty liver disease (NAFLD): the available clinical evidence. Nutrients. 2018;10(9):1153.","journal-title":"Nutrients"},{"key":"485_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ebiom.2017.12.027","volume":"28","author":"N Wang","year":"2018","unstructured":"Wang N, Chen C, Zhao L, et al. Vitamin D and nonalcoholic fatty liver disease: bi-directional Mendelian randomization analysis. EBioMedicine. 2018;28:187\u201393.","journal-title":"EBioMedicine"},{"issue":"4","key":"485_CR26","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jhep.2011.08.025","volume":"56","author":"LP Bechmann","year":"2012","unstructured":"Bechmann LP, Hannivoort RA, Gerken G, et al. The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol. 2012;56(4):952\u201364.","journal-title":"J Hepatol"},{"key":"485_CR27","doi-asserted-by":"crossref","unstructured":"Cheung O, Sanyal AJ, editors. Abnormalities of lipid metabolism in nonalcoholic fatty liver disease. Seminars in liver disease: \u00a9 Thieme Medical Publishers; 2008.","DOI":"10.1055\/s-0028-1091979"},{"key":"485_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1365-2036.2005.02601.x","volume":"22","author":"E Albano","year":"2005","unstructured":"Albano E, Mottaran E, Occhino G, et al. Role of oxidative stress in the progression of non-alcoholic steatosis. Aliment Pharmacol Ther. 2005;22:71\u20133.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"485_CR29","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/apt.12377","volume":"38","author":"M Eliades","year":"2013","unstructured":"Eliades M, Spyrou E, Agrawal N, et al. Meta-analysis: vitamin D and non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2013;38(3):246\u201354.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"485_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1476-511X-11-42","volume":"11","author":"H Wang","year":"2012","unstructured":"Wang H, Xia N, Yang Y, et al. Influence of vitamin D supplementation on plasma lipid profiles: a meta-analysis of randomized controlled trials. Lipids Health Dis. 2012;11(1):42.","journal-title":"Lipids Health Dis"},{"key":"485_CR31","doi-asserted-by":"publisher","first-page":"S975","DOI":"10.1016\/j.dsx.2017.07.025","volume":"11","author":"R Tabrizi","year":"2017","unstructured":"Tabrizi R, Moosazadeh M, Lankarani KB, et al. The effects of vitamin D supplementation on metabolic profiles and liver function in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. Diabetes Metab Syndr. 2017;11:S975\u2013S82.","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"485_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.phrs.2009.03.005","volume":"60","author":"S-E Jin","year":"2009","unstructured":"Jin S-E, Park J-S, Kim C-K. Pharmacokinetics of oral calcitriol in healthy human based on the analysis with an enzyme immunoassay. Pharmacol Res. 2009;60(1):57\u201360.","journal-title":"Pharmacol Res"},{"issue":"9","key":"485_CR33","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3390\/nu9091015","volume":"9","author":"I Barchetta","year":"2017","unstructured":"Barchetta I, Cimini F, Cavallo M. Vitamin D supplementation and non-alcoholic fatty liver disease: present and future. Nutrients. 2017;9(9):1015.","journal-title":"Nutrients"},{"key":"485_CR34","doi-asserted-by":"crossref","unstructured":"Mansour-Ghanaei F, Pourmasoumi M, Hadi A, et al. The efficacy of vitamin D supplementation against nonalcoholic fatty liver disease: a meta-analysis. J Diet Suppl. 2020;17(4):467\u201385.","DOI":"10.1080\/19390211.2019.1624671"},{"issue":"7","key":"485_CR35","first-page":"424","volume":"22","author":"S Shaheen","year":"2012","unstructured":"Shaheen S, Noor SS, Barakzai Q. Serum alkaline phosphatase screening for vitamin D deficiency states. J Coll Physicians Surg Pak. 2012;22(7):424\u20137.","journal-title":"J Coll Physicians Surg Pak"},{"issue":"2","key":"485_CR36","first-page":"329","volume":"24","author":"R Tanabe","year":"2015","unstructured":"Tanabe R, Kawamura Y, Tsugawa N, et al. Effects of\u2019 Fok-I\u2019polymorphism in vitamin D receptor gene on serum 25-hydroxyvitamin D, bone-specific alkaline phosphatase and calcaneal quantitative ultrasound parameters in young adults. Asia Pac J Clin Nutr. 2015;24(2):329.","journal-title":"Asia Pac J Clin Nutr"},{"issue":"2","key":"485_CR37","volume":"17","author":"N Montazeri-Najafabady","year":"2019","unstructured":"Montazeri-Najafabady N, Dabbaghmanesh MH, Mohammadian Amiri R, et al. Association of Vitamin D Receptor BsmI gene polymorphism with BMD Z-score in Iranian children and adolescents (9 - 18 years old). Int J Endocrinol Metab. 2019;17(2):e82677.","journal-title":"Int J Endocrinol Metab"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-021-00485-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40360-021-00485-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-021-00485-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T12:28:05Z","timestamp":1617798485000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-021-00485-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,7]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["485"],"URL":"https:\/\/doi.org\/10.1186\/s40360-021-00485-y","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,7]]},"assertion":[{"value":"23 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was approved by the Ethics Committee of Ahvaz Jundishapur University of Medical Sciences. The participants provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}